Dianthus Therapeutics, Inc. /DE/ (DNTH) ROA
- 2026-06-30: ROA -15.85%.
- 2026-03-31: ROA -13.93%.
- 2025-12-31: ROA -30.58%.
- 2025-09-30: ROA -21.88%.
Complete source-backed roa history.
- Available history
- 2017-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|
| 2026-06-30 | -15.85% |
|---|
| 2026-03-31 | -13.93% |
|---|
| 2025-12-31 | -30.58% |
|---|
| 2025-09-30 | -21.88% |
|---|
| 2025-06-30 | -35.19% |
|---|
| 2025-03-31 | -28.90% |
|---|
| 2024-12-31 | -22.72% |
|---|
| 2024-09-30 | -18.94% |
|---|
| 2024-06-30 | -15.36% |
|---|
| 2024-03-31 | -13.13% |
|---|
| 2023-12-31 | -24.28% |
|---|
| 2023-09-30 | -22.40% |
|---|
| 2023-06-30 | -45.94% |
|---|
| 2023-03-31 | -36.77% |
|---|
| 2022-12-31 | -34.26% |
|---|
| 2022-09-30 | -22.94% |
|---|
| 2022-06-30 | -27.01% |
|---|
| 2022-03-31 | -30.11% |
|---|
| 2021-12-31 | -37.45% |
|---|
| 2021-09-30 | -33.95% |
|---|
| 2021-06-30 | -31.88% |
|---|
| 2021-03-31 | -50.07% |
|---|
| 2020-12-31 | -46.37% |
|---|
| 2020-09-30 | -45.81% |
|---|
| 2020-06-30 | -43.68% |
|---|
| 2020-03-31 | -56.73% |
|---|
| 2019-12-31 | -47.53% |
|---|
| 2019-09-30 | -39.62% |
|---|
| 2019-06-30 | -33.38% |
|---|
| 2019-03-31 | -41.43% |
|---|
| 2018-12-31 | -36.56% |
|---|
| 2018-09-30 | -28.28% |
|---|
| 2018-06-30 | -22.02% |
|---|
Annual ROA
| Date | ROA |
|---|
| 2025-12-31 | -30.58% |
|---|
| 2024-12-31 | -22.72% |
|---|
| 2023-12-31 | -24.28% |
|---|
| 2022-12-31 | -34.26% |
|---|
| 2021-12-31 | -37.45% |
|---|
| 2020-12-31 | -46.37% |
|---|
| 2019-12-31 | -47.53% |
|---|
| 2018-12-31 | -36.56% |
|---|
| 2017-12-31 | -65.17% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|